A phase II study of bi-weekly pegylated liposomal doxorubicin and paclitaxel in metastatic breast canecer (MBC) patients (pts)

被引：0
|
作者：
Ferrari, Vittori D. [1 ]
Simoncini, Edda [1 ]
Amoroso, Vito [1 ]
Grisanti, Salvatore [1 ]
Valcamonico, Francesca [1 ]
Vassalli, Lucia [1 ]
Marpicati, Patrizia [1 ]
Rangoni, Giovanni [1 ]
Marini, Giovanni [1 ]
机构：
[1] Azienda Spedali Civili, UO Oncol Med & Fdn Beretta, Brescia, Italy
来源：
ANNALS OF ONCOLOGY | 2004年 / 15卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：49 / 49
页数：1
相关论文
共 50 条
  • [1] Bi-weekly administration of pegylated liposomal doxorubicin plus paclitaxel in metastatic breast cancer (MBC) patients: A phase II study.
    Simoncini, E
    Ferrari, VD
    Amoroso, V
    Valcamonico, F
    Grisanti, S
    Vassalli, L
    Marpicati, P
    Montini, E
    Rangoni, G
    Marini, G
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 88S - 88S
  • [2] Weekly pegylated liposomal doxorubicin and paclitaxel in patients with metastatic breast carcinoma: A phase II study
    Leonardi, Vita
    Palmisano, Valentina
    Pepe, Alessio
    Usset, Antonella
    Manuguerra, Giovanna
    Savio, Giuseppina
    De Bella, Manuela Tamburo
    Laudani, Agata
    Alu, Massimo
    Cusimano, Maria Pia
    Scianna, Caterina
    Giresi, Armando
    Agostara, Biagio
    [J]. ONCOLOGY LETTERS, 2010, 1 (04) : 749 - 753
  • [3] Weekly paclitaxel and pegylated liposomal doxorubicin in metastatic breast carcinoma
    Leonardi, V.
    Palmisano, V.
    Pepe, A.
    Usset, A.
    Savio, G.
    Laudani, A.
    Calabria, C.
    Tartaglia, L.
    Amari, P.
    Carruba, G.
    Agostara, B.
    [J]. ANNALS OF ONCOLOGY, 2007, 18 : 55 - 55
  • [4] The effect of bi-weekly pegylated liposomal doxorubicin pharmacokinetics in elderly women with metastatic breast carcinoma
    Gusella, M.
    Basso, U.
    Pasini, F.
    Ferrazzi, E.
    Bononi, A.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [5] TOXICITY OF WEEKLY LIPOSOMAL DOXORUBICIN AND PACLITAXEL IN METASTATIC BREAST CANCER (MBC)
    Longo, F.
    Pellegrini, P.
    Ceccarelli, F.
    Borgomastro, A.
    Comito, T.
    Basile, M. L.
    De Biasio, G.
    Girolami, M.
    Spalletta, B.
    Di Seri, M.
    [J]. ANNALS OF ONCOLOGY, 2004, 15 : 23 - 23
  • [6] Weekly paclitaxel (T) and pegylated liposomal doxorubicin (PLD) as first line treatment in metastatic breast cancer (MBC) patients.
    Fulfaro, F
    Valerio, MR
    Badalamenti, G
    Arcara, C
    Cicero, G
    Intrivici, C
    Crosta, A
    Sciortino, C
    Russo, A
    Gebbia, N
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 53S - 53S
  • [7] Pegylated liposomal doxorubicin (PLD) and gemcitabine (G) in metastatic breast cancer (MBC) patients: A phase II study.
    Fabi, A
    Papaldo, P
    Ciccarese, M
    Salesi, N
    Lorusso, V
    Ferretti, G
    Carlini, P
    Sacchi, I
    Cecere, F
    Cognetti, F
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 80S - 80S
  • [8] Pegylated liposomal doxorubicin (PEG-LD) and paclitaxel in patients with metastatic breast carcinoma: A phase II study
    Leonardi, V
    Palmisano, V
    Pepe, A.
    Usset, A.
    Savio, G.
    Laudani, A.
    Calabria, C.
    Giresi, A.
    Carruba, G.
    Agostara, B.
    [J]. ANNALS OF ONCOLOGY, 2006, 17 : XI10 - XI10
  • [9] Pegylated liposomal doxorubicin (Peg-LD) and paclitaxel in patients with metastatic breast carcinoma: A phase II study
    Leonardi, Vita
    Palmisano, Valentina
    Pepe, Alessio
    Usset, Antonella
    Savio, Giuseppina
    Laudani, Agata
    Calabria, Caterina
    Rondello, Giacomo
    Carruba, Giuseppe
    Agostara, Biagio
    [J]. ANNALS OF ONCOLOGY, 2006, 17 : 85 - 85
  • [10] Pegylated liposomal doxorubicin (PEG-LD) and paclitaxel in patients with metastatic breast carcinoma: A phase II study
    Leonardi, V.
    Palmisano, V.
    Pepe, A.
    Savio, G.
    Laudani, A.
    De Bella, M. Tamburo
    Mesi, L.
    Agostana, B.
    [J]. ANNALS OF ONCOLOGY, 2005, 16 : 144 - 144
12345